NaturalAntibody is a bioinformatics company that brings to market analytical tools and databases that allow pharmaceutical companies to significantly reduce the time and cost associated with bringing antibody-based drugs to market. By leveraging these tools, the company optimizes the development process for new biological drugs, including immunotherapies used in cancer treatment. The flagship product is a comprehensive platform powered by machine learning algorithms and the world’s largest collection of antibody databases, which aggregate 40 years of data. NaturalAntibody's clients include pharmaceutical giants like AstraZeneca and Bayer.

Founded by experts with a blend of academic experience from institutions such as the University of Oxford and Denmark, along with proven success in global business ventures, the company operates in Europe, the USA, Japan, and China.